Keyword: Johnson & Johnson
News
03.07.2014
- Swiss-based Roche Holding AG plans to pay up to $1.73 billion to buy Seragon Pharmaceuticals, a privately-held US biotech company that researches breast cancer treatments. Roche...
News
02.06.2014
- German drugmaker Boehringer Ingelheim has said it will pay about $650 million to settle US lawsuits that claimed the company's blockbuster blood thinner, Pradaxa (dabigatran)...
Strategy & Management
08.05.2014
- In contrast to chemicals, the global pharmaceutical industry is little plagued by market cyclicality or general economic swings. But it faces equally daunting challenges, as the...
News
07.05.2014
- As expected, Germany's Bayer has emerged as the winner of the race to acquire U.S. Merck's consumer care business. The $14.2 billion deal announced on May 5 is expected to close in...
News
28.04.2014
- U.S.-based Zimmer Holdings has said it will buy rival orthopedic products maker Biomet for more than $13 billion, the latest deal in a wave of consolidations in the healthcare...
News
18.04.2014
- The global private equity industry will see more listed players in coming years, while focusing more on emerging markets, less on leverage and more on good management of their...
News
28.02.2014
- In a deal expected to close in the second half of 2014, Bayer has said it will buy privately held Dihon Pharmaceutical Group, a maker of traditional herbal Chinese medicines (TCM)...
News
21.02.2014
- A handful of consumer and healthcare companies including Germany's Bayer and Switzerland's Novartis are exploring a deal for Merck & Co's consumer healthcare business, people...
